JP2011513431A5 - - Google Patents

Download PDF

Info

Publication number
JP2011513431A5
JP2011513431A5 JP2010549910A JP2010549910A JP2011513431A5 JP 2011513431 A5 JP2011513431 A5 JP 2011513431A5 JP 2010549910 A JP2010549910 A JP 2010549910A JP 2010549910 A JP2010549910 A JP 2010549910A JP 2011513431 A5 JP2011513431 A5 JP 2011513431A5
Authority
JP
Japan
Prior art keywords
phenyl
compound
cyano
acceptable salt
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010549910A
Other languages
English (en)
Japanese (ja)
Other versions
JP5382952B2 (ja
JP2011513431A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/036333 external-priority patent/WO2009111700A2/en
Publication of JP2011513431A publication Critical patent/JP2011513431A/ja
Publication of JP2011513431A5 publication Critical patent/JP2011513431A5/ja
Application granted granted Critical
Publication of JP5382952B2 publication Critical patent/JP5382952B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010549910A 2008-03-07 2009-03-06 糖尿病の治療のためのオキサジアゾアントラセン化合物 Active JP5382952B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3459908P 2008-03-07 2008-03-07
US61/034,599 2008-03-07
PCT/US2009/036333 WO2009111700A2 (en) 2008-03-07 2009-03-06 Oxadiazoanthracene compounds for the treatment of diabetes

Publications (3)

Publication Number Publication Date
JP2011513431A JP2011513431A (ja) 2011-04-28
JP2011513431A5 true JP2011513431A5 (enExample) 2013-02-14
JP5382952B2 JP5382952B2 (ja) 2014-01-08

Family

ID=41056666

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010549910A Active JP5382952B2 (ja) 2008-03-07 2009-03-06 糖尿病の治療のためのオキサジアゾアントラセン化合物

Country Status (17)

Country Link
US (7) US7727983B2 (enExample)
EP (1) EP2262364B1 (enExample)
JP (1) JP5382952B2 (enExample)
KR (1) KR101616737B1 (enExample)
CN (1) CN101959405B (enExample)
AU (1) AU2009221722B2 (enExample)
BR (1) BRPI0910282A2 (enExample)
CA (1) CA2716664C (enExample)
DK (1) DK2262364T3 (enExample)
EA (1) EA018225B1 (enExample)
ES (1) ES2567451T3 (enExample)
IL (1) IL207570A (enExample)
MA (1) MA32175B1 (enExample)
MX (1) MX2010009752A (enExample)
NZ (1) NZ587343A (enExample)
WO (1) WO2009111700A2 (enExample)
ZA (1) ZA201006367B (enExample)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009221722B2 (en) * 2008-03-07 2014-12-18 Vtv Therapeutics Llc Oxadiazoanthracene compounds for the treatment of diabetes
EA023430B1 (ru) 2009-03-30 2016-06-30 виТиви ТЕРАПЬЮТИКС ЭлЭлСи Замещенные производные азоантрацена, фармацевтические композиции и способы их применения
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
DE102010015123A1 (de) 2010-04-16 2011-10-20 Sanofi-Aventis Deutschland Gmbh Benzylamidische Diphenylazetidinone, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
RU2013127611A (ru) 2010-12-23 2015-01-27 Пфайзер Инк. Модуляторы глюкагонового рецептора
WO2012096824A1 (en) * 2011-01-12 2012-07-19 Transtech Pharma, Inc. Phenylglyoxylic acid derivatives and their preparation and use
MX2013009140A (es) 2011-02-08 2013-10-01 Pfizer Moduladores del receptor de glucagon.
RU2013157388A (ru) 2011-07-22 2015-08-27 Пфайзер Инк. Хинолинильные модуляторы глюкагонового рецептора
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
JP2015510947A (ja) * 2012-03-22 2015-04-13 トランステック・ファーマ,エルエルシー 小分子glp1rアゴニストのトリス(ヒドロキシメチル)アミノメタン塩ならびにその医薬組成物および使用
IN2015DN03795A (enExample) 2012-10-24 2015-10-02 Inserm Inst Nat De La Santé Et De La Rech Médicale
CN104968341B (zh) 2013-01-17 2020-06-09 Vtv治疗有限责任公司 Glp1r激动剂和二甲双胍的组合及其在制备治疗2型糖尿病和其他障碍的药物中的用途
CA2955836C (en) * 2014-07-25 2023-02-14 Celgene International Ii Sarl Glp-1 receptor modulators
US10426818B2 (en) 2015-03-24 2019-10-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Method and pharmaceutical composition for use in the treatment of diabetes
JOP20190060A1 (ar) 2016-09-26 2019-03-26 Chugai Pharmaceutical Co Ltd مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1
TW201925204A (zh) * 2017-11-22 2019-07-01 日商第一三共股份有限公司 稠合三環化合物
KR20210005843A (ko) 2018-05-08 2021-01-15 브이티브이 테라퓨틱스 엘엘씨 Glp1r 작용제의 치료적 용도
EA202191432A1 (ru) 2018-11-22 2021-10-14 Цилу Регор Терапьютикс Инк. Агонисты glp-1r и их применения
WO2020207474A1 (en) * 2019-04-12 2020-10-15 Qilu Regor Therapeutics Inc. Glp-1r agonists and uses thereof
CN115315426B (zh) 2020-04-01 2023-12-12 杭州中美华东制药有限公司 Glp-1受体激动剂游离碱的药学上可接受的酸式盐及其制备方法
EP4130005A4 (en) 2020-04-01 2024-04-24 Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. CRYSTALLINE FORM A OF A GLP-1 RECEPTOR AGONIST AND METHOD OF MANUFACTURING THEREOF
TW202144340A (zh) 2020-04-03 2021-12-01 大陸商江蘇恆瑞醫藥股份有限公司 稠合咪唑類衍生物、其製備方法及其在醫藥上的應用
TW202210461A (zh) * 2020-05-28 2022-03-16 中國大陸商杭州中美華東製藥有限公司 一種(s)—2—胺基—3—(4—(2,3—二甲基吡啶—4—基)苯基)丙酸甲酯二酸鹽的製備方法
EP4159737A4 (en) * 2020-05-28 2024-10-09 Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. METHOD FOR PREPARING A GLP-1 RECEPTOR AGONIST-FREE BASE
JP2023539584A (ja) 2020-09-01 2023-09-15 江蘇恒瑞医薬股▲ふん▼有限公司 縮合イミダゾール誘導体、その調製方法及びその医薬的応用
WO2022078152A1 (zh) 2020-10-12 2022-04-21 杭州中美华东制药有限公司 苯并咪唑酮类glp-1受体激动剂及其用途
US20230382899A1 (en) * 2020-10-14 2023-11-30 Qilu Regor Therapeutics Inc. Crystal forms of glp-1r agonists and uses thereof
EP4247804A1 (en) 2020-11-20 2023-09-27 Gilead Sciences, Inc. Polyheterocyclic glp-1 r modulating compounds
CA3200245A1 (en) 2020-11-27 2022-06-02 Junjun Wu Benzimidazole derivative and preparation method therefor and medical use thereof
CN116940561A (zh) 2021-03-22 2023-10-24 杭州中美华东制药有限公司 噻吩类glp-1受体激动剂及其用途
EP4317145A4 (en) 2021-03-24 2025-03-12 Shionogi & Co., Ltd Pharmaceutical composition containing glp-1 receptor agonist having fused ring
WO2022262615A1 (zh) * 2021-06-17 2022-12-22 杭州中美华东制药有限公司 蒽类化合物、其制备方法和医药用途
AU2022300055A1 (en) 2021-06-24 2024-01-18 Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. Glp-1 receptor agonist and composition and use thereof
CN115521320B (zh) * 2021-06-25 2023-09-05 沈阳兴齐眼药股份有限公司 一种制备普拉洛芬的方法
WO2024063143A1 (ja) 2022-09-22 2024-03-28 塩野義製薬株式会社 Glp-1受容体アゴニスト作用を有する縮合環化合物
CN120981457A (zh) 2023-09-14 2025-11-18 歌礼制药(中国)有限公司 Glp-1r激动剂及其治疗方法
US12291530B1 (en) 2023-11-24 2025-05-06 Ascletis Pharma (China) Co., Limited GLP-1R agonist and therapeutic method thereof
WO2025158275A1 (en) 2024-01-24 2025-07-31 Pfizer Inc. Combination therapy using glucose-dependent insulinotropic polypeptide receptor antagonist compounds and glp-1 receptor agonist compounds
WO2025189141A1 (en) 2024-03-08 2025-09-12 Annapurna Bio, Inc. Methods for treating obesity and increasing weight loss

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6345270A (ja) * 1986-02-11 1988-02-26 Takeda Chem Ind Ltd 1,4−ベンゾオキサジン誘導体,その製造法およびそれを含有する医薬用組成物
EP0233728A1 (en) 1986-02-11 1987-08-26 Takeda Chemical Industries, Ltd. 1,4-Benzoxazine derivatives their production and use
EP0873295B1 (en) * 1995-10-06 2003-04-02 Ligand Pharmaceuticals, Inc. Dimer-selective rxr modulators and methods for their use
EP1147094A1 (en) * 1999-01-15 2001-10-24 Novo Nordisk A/S Non-peptide glp-1 agonists
WO2001040192A1 (en) * 1999-12-03 2001-06-07 Kyoto Pharmaceutical Industries, Ltd. Novel heterocyclic compounds and salts thereof and medicinal use of the same
EP1125925A1 (en) * 2000-02-15 2001-08-22 Applied Research Systems ARS Holding N.V. Amine derivatives for the treatment of apoptosis
US20050222036A1 (en) 2000-08-24 2005-10-06 Thomas Jefferson University Peptide compositions with effects on blood glucose
ATE435210T1 (de) * 2003-03-26 2009-07-15 Actelion Pharmaceuticals Ltd Tetrahydroisochinolylacetamidderivate zur verwendung als orexinrezeptorantagonisten
AU2009221722B2 (en) * 2008-03-07 2014-12-18 Vtv Therapeutics Llc Oxadiazoanthracene compounds for the treatment of diabetes
EP2579888A2 (en) 2010-06-09 2013-04-17 Receptos, Inc. Novel glp-1 receptor stabilizers and modulators

Similar Documents

Publication Publication Date Title
JP2011513431A5 (enExample)
KR101276449B1 (ko) 치료제로서의 치환된 감마 락탐
KR101367553B1 (ko) 12-아릴 프로스타글란딘 유사체
JP5525500B2 (ja) 1h−キナゾリン−2,4−ジオンおよびampa受容体リガンドとしてのそれらの使用
WO2013158649A1 (en) Compositions and methods of modulating 15-pgdh activity
AU2004240649A1 (en) Immunosuppressant compounds and compositions
CN114555574A (zh) 靶向醛酮还原酶1c3的苯并二氢吡喃类化合物
JP2009541340A (ja) 治療用化合物
US20070203222A1 (en) Substituted gamma lactams as therapeutic agents
JP2009534398A5 (enExample)
JP2010528089A5 (enExample)
JP2010513435A5 (enExample)
AU2003240714B2 (en) Bis-aromatic alkanols
CN109996797B (zh) 作为乳酸脱氢酶的抑制剂的1h-吡唑-1-基-噻唑及其使用方法
JP5410438B2 (ja) 治療用置換ラクタム類
JP2005520814A (ja) HMG−CoA還元酵素阻害剤の製造法
JP5501760B2 (ja) 治療薬としての置換ガンマラクタム類
EP2170345A1 (en) Therapeutic substituted cyclopentanes for reducing intraocular pressure
JP2010516778A (ja) 治療薬としての置換アリールシクロペンテン類
US20040176614A1 (en) Process for the preparation of indole derivatives and intermediates of the process
CN101119747A (zh) 组织因子产生抑制剂
KR20100087931A (ko) 로슈바스타틴의 전구체 및 그의 제조 방법
CN105399737B (zh) 噁唑烷酮类化合物及其用途
TW202246204A (zh) 苯酚衍生物及其在醫藥上的應用
CA2787914C (en) Therapeutic agents for treatment of ocular hypertension